|
|
||||||||
From the Department of Neurological and Psychiatrical Sciences (Drs. Perini and Gallo), Multiple Sclerosis Centre, University of Padova; Section of Immunohaematology and Blood Transfusion Centre (C. Tagliaferri and Dr. Belloni), General Hospital of Vicenza; and Department of Experimental Pathology (G. Biasi), University of Ancona, Italy.
Address correspondence and reprint requests to Dr. Paolo Gallo, First Neurology Clinic, Department of Neurological & Psychiatrical Sciences, University of Padova, via Giustiniani 5, 35128 Padova; e-mail: pgallo{at}ux1.unipd.it
This article has been cited by other articles:
![]() |
S. Strasser-Fuchs, C. Enzinger, S. Ropele, M. Wallner, and F. Fazekas Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox? Multiple Sclerosis, March 1, 2008; 14(2): 205 - 211. [Abstract] [PDF] |
||||
![]() |
H. Schmidt, D. Williamson, and A. Ashley-Koch HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review Am. J. Epidemiol., May 15, 2007; 165(10): 1097 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Al-Shammri, R F Nelson, I Al-Muzairi, and A O Akanji HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population Multiple Sclerosis, August 1, 2004; 10(4): 381 - 386. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |